1,526
Views
8
CrossRef citations to date
0
Altmetric
Review

Association of Body Mass Index with Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

, , , &
Pages 101-113 | Received 30 Nov 2020, Accepted 28 Jan 2021, Published online: 16 Feb 2021

References

  • Cho WK, Lee CG, Kim LK. COPD as a disease of immunosenescence. Yonsei Med J. 2019;60(5):407–413. DOI:10.3349/ymj.2019.60.5.407
  • Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. DOI:10.1183/09031936.00128008
  • Criner RN, Han MK. COPD care in the 21st century: a public health priority. Respir Care. 2018;63(5):591–600. DOI:10.4187/respcare.06276
  • Ford ES, Croft JB, Mannino DM, et al. COPD surveillance–United States, 1999-2011. Chest. 2013;144(1):284–305. DOI:10.1378/chest.13-0809
  • López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI:10.1111/resp.12660
  • Behrens G, Matthews CE, Moore SC, et al. Body size and physical activity in relation to incidence of chronic obstructive pulmonary disease. CMAJ. 2014;186(12):E457–E469. DOI:10.1503/cmaj.140025
  • Szmidt MK, Kaluza J, Harris HR, et al. Long-term dietary fiber intake and risk of chronic obstructive pulmonary disease: a prospective cohort study of women. Eur J Nutr. 2020;59(5):1869–1879. DOI:10.1007/s00394-019-02038-w
  • Park HJ, Byun MK, Kim HJ, et al. Dietary vitamin C intake protects against COPD: the Korea National Health and Nutrition Examination Survey in 2012. COPD. 2016;11:2721–2728. DOI:10.2147/COPD.S119448
  • Jiménez-Cepeda A, Dávila-Said G, Orea-Tejeda A, et al. Dietary intake of fatty acids and its relationship with FEV1/FVC in patients with chronic obstructive pulmonary disease. Clin Nutr Espen. 2019;29:92–96. DOI:10.1016/j.clnesp.2018.11.015
  • Liu SM, Zhou YM, Wang XP, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax. 2007;62(10):889–897. DOI:10.1136/thx.2006.061457
  • Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. DOI:10.1164/rccm.200612-1749OC
  • Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000;53(7):755–761. DOI:10.1016/S0895-4356(99)00211-5
  • Kanervisto M, Vasankari T, Laitinen T, et al. Low socioeconomic status is associated with chronic obstructive airway diseases. Respir Med. 2011;105(8):1140–1146. DOI:10.1016/j.rmed.2011.03.008
  • NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–1396.
  • Mak K-K, Tan SH. Underweight problems in Asian children and adolescents. Eur J Pediatr. 2012;171(5):779–785. DOI:10.1007/s00431-012-1685-9
  • Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10. DOI:10.1016/j.metabol.2018.09.005
  • Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755–767. DOI:10.1080/17476348.2018.1506331
  • Li H, Xu B, Zheng W. The prevalence of obesity in middle-aged and old men and its relationship with chronic diseases. Chinese J Epidemiol. 2010;31(4):370–374.
  • Zhou Y, Wang D, Liu S, et al. The association between BMI and COPD: the results of two population-based studies in Guangzhou, China. COPD. 2013;10(5):567–572. DOI:10.3109/15412555.2013.781579
  • Fuller-Thomson E, Howden KEN, Fuller-Thomson LR, et al. A strong graded relationship between level of obesity and COPD: findings from a national population-based study of lifelong nonsmokers. J Obes. 2018;2018:1–9. DOI:10.1155/2018/6149263
  • Daldoul H, Denguezli M, Jithoo A, et al. Prevalence of COPD and tobacco smoking in Tunisia–results from the BOLD study. Int J Environ Res Public Health. 2013;10(12):7257–7271. DOI:10.3390/ijerph10127257
  • Park H, Jung SY, Lee K, et al. Prevalence of chronic obstructive lung disease in Korea using data from the fifth Korea national health and nutrition examination survey. Korean J Fam Med. 2015;36(3):128–134. DOI:10.4082/kjfm.2015.36.3.128
  • Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33(3):509–518. DOI:10.1183/09031936.00084408
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. DOI:10.1164/rccm.201701-0218PP
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. DOI:10.1136/bmj.327.7414.557
  • Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest. 2002;121(2):370–376. DOI:10.1378/chest.121.2.370
  • García Rodríguez LA, Wallander MA, Tolosa LB, et al. Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. Copd. 2009;6(5):369–379. DOI:10.1080/15412550903156325
  • Na J, Hu T, Zhao S, et al. Epidemiological investigation of chronic obstructive pulmonary disease in Uighur population over 60 years old in rural Hotan, Xinjiang. J XinJiang Med Univ. 2010;33(09):1017–1020.
  • Tran HN, Siu S, Iribarren C, et al. Ethnicity and risk of hospitalization for asthma and chronic obstructive pulmonary disease. Ann Epidemiol. 2011;21(8):615–622. DOI:10.1016/j.annepidem.2010.10.015
  • Tarride JE, Haq M, Taylor VH, et al. Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res. 2012;4:21–30. DOI:10.2147/CEOR.S24192
  • Alam DS, Chowdhury MA, Siddiquee AT, et al. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD. 2015;12(6):658–667.
  • Ding YP, Xu JX, Yao JJ, et al. The analyses of risk factors for COPD in the Li ethnic group in Hainan, People's Republic of China. Int J Chron Obstruct Pulmon Dis. 2015;10:2593–2599.
  • Lee SJ, Kim SW, Kong KA, et al. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015;10:497–506.
  • Liu S, Ren Y, Wen D, et al. Prevalence and risk factors for COPD in greenhouse farmers: a large, cross-sectional survey of 5,880 farmers from northeast China. Int J Chron Obstruct Pulmon Dis. 2015;10:2097–2108. DOI:10.2147/COPD.S79264
  • Martin-Rodriguez E, Guillen-Grima F, Marti A, et al. Comorbidity associated with obesity in a large population: the APNA study. Obes Res Clin Pract. 2015;9(5):435–447. DOI:10.1016/j.orcp.2015.04.003
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. DOI:10.1016/S0140-6736(18)30841-9
  • Zhao C, Wong L, Zhu Q, et al. Prevalence and correlates of chronic diseases in an elderly population: a community-based survey in Haikou. PLoS One. 2018;13(6):e0199006. DOI:10.1371/journal.pone.0199006
  • Dong T, Xu X, Chen X, et al. Study on the risk factors of COPD in non-smokers in Sichuan Province. J Prev Med Inform. 2018;34(5):582–585.
  • Tang Y, Li Q, Zhang L, et al. Epidemiological investigation and influencing factors of chronic obstructive pulmonary disease in Hubei Province. Chinese J Dis Control. 2018;22(7):721–725.
  • Katsimigas A, Tupper OD, Ulrik CS. Opportunistic screening for COPD in primary care: a pooled analysis of 6,710 symptomatic smokers and ex-smokers. COPD. 2019;14:1633–1638. DOI:10.2147/COPD.S204190
  • Park HJ, Cho JH, Kim HJ, et al. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality. J Intern Med. 2019;286(5):573–582. DOI:10.1111/joim.12949
  • Li J, Lv J, Gao M, et al. The relationship between body mass index and waist circumference and the risk of major chronic diseases in Chinese adults. Chinese J Epidemiol. 2019;40(12):1541–1547.
  • Zha Z, Leng R, Xu W, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in Anhui Province, China: a population-based survey. BMC Pulm Med. 2019;19(1):102. DOI:10.1186/s12890-019-0864-0
  • Osman S, Ziegler C, Gibson R, et al. The association between risk factors and chronic obstructive pulmonary disease in Canada: a cross-sectional study using the 2014 Canadian Community Health Survey. Int J Prev Med. 2017;8(1):86. DOI:10.4103/ijpvm.IJPVM_330_17
  • Li J, Zhu L, Wei Y, et al. Association between adiposity measures and COPD risk in Chinese adults. Eur Respir J. 2020;55(4):1901899. DOI:10.1183/13993003.01899-2019
  • Charususin N, Dacha S, Gosselink R, et al. Respiratory muscle function and exercise limitation in patients with chronic obstructive pulmonary disease: a review. Expert Rev Respir Med. 2018;12(1):67–79. DOI:10.1080/17476348.2018.1398084
  • Sun Y, Milne S, Jaw JE, et al. BMI is associated with FEV(1) decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respir Res. 2019;20(1):236. DOI:10.1186/s12931-019-1209-5
  • Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr. 2005;82(5):996–1003. DOI:10.1093/ajcn/82.5.996
  • Guenette JA, Jensen D, O’donnell DE. Respiratory function and the obesity paradox. Curr Opin Clin Nutr Metab Care. 2010;13(6):618–624. DOI:10.1097/MCO.0b013e32833e3453
  • Carbone S, Billingsley HE, Rodriguez-Miguelez P, et al. Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol. 2020;45(11):100417. DOI:10.1016/j.cpcardiol.2019.03.006
  • Park CH, Yi Y, Do JG, et al. Relationship between skeletal muscle mass and lung function in Korean adults without clinically apparent lung disease. Medicine (Baltimore). 2018;97(37):e12281.
  • Gea J, Pascual S, Casadevall C, et al. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015;7(10):E418–E438. DOI:10.3978/j.issn.2072-1439.2015.08.04
  • Schembri S, Anderson W, Morant S, et al. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med. 2009;103(10):1461–1467. DOI:10.1016/j.rmed.2009.04.021
  • Lennon H, Sperrin M, Badrick E, et al. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18(9):56. DOI:10.1007/s11912-016-0539-4
  • Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61(2):142–150. DOI:10.1016/j.pcad.2018.07.003
  • Keller K, Hobohm L, Münzel T, et al. Survival benefit of obese patients with pulmonary embolism. Mayo Clin Proc. 2019;94(10):1960–1973. DOI:10.1016/j.mayocp.2019.04.035
  • Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord. 2018;23(1):15–22. DOI:10.1007/s40519-017-0456-z
  • Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2003;123(5):1460–1466. DOI:10.1378/chest.123.5.1460
  • Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo, Brazil). 2010;65(6):599–605. DOI:10.1590/S1807-59322010000600007
  • Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD. 2015;12(1):14–18. DOI:10.3109/15412555.2014.915934
  • Reito A, Launonen A, Paloneva J. Factors explaining heterogeneity in studies comparing surgical and nonsurgical treatment of midshaft clavicle fractures: a meta-regression analysis of randomized controlled trials and high-quality observational studies. J Shoulder Elbow Surg. 2020;29(8):1726–1734. DOI:10.1016/j.jse.2020.02.011
  • Ho T, Cusack RP, Chaudhary N, et al. Under- and over-diagnosis of COPD: a global perspective. Breathe (Sheff). 2019;15(1):24–35. DOI:10.1183/20734735.0346-2018
  • Patel S, Ram F, Patel SK, et al. Association of behavioral risk factors with self-reported and symptom or measured chronic diseases among adult population (18-69 years) in India: evidence from SAGE study. BMC Public Health. 2019;19(1):560. DOI:10.1186/s12889-019-6953-4
  • Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009;34(3):588–597. DOI:10.1183/09031936.00164608
  • Wang S, Gong W, Tian Y, et al. Voluntary pulmonary function screening with GOLD standard: an effective and simple approach to detect lung obstruction. J Thorac Dis. 2015;7(11):1970–1977. DOI:10.3978/j.issn.2072-1439.2015.11.20
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. DOI:10.1183/09031936.05.00035205
  • Miller MR. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax. 2014;69(12):1145–1146. DOI:10.1136/thoraxjnl-2014-205960
  • Oh SW, Shin SA, Yun YH, et al. Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res. 2004;12(12):2031–2040. DOI:10.1038/oby.2004.254

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.